Back
TG Therapeutics 10K Form
Buy
60
TGTX
TG Therapeutics
Last Price:
$32.22
Seasonality Move:
63.62%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TGTX News And Ratings
See the #1 stock for the next 7 days that we like better than TGTX
TGTX Financial Statistics
Sales & Book Value
| Annual Sales: | $233.7M |
|---|---|
| Cash Flow: | $-12.2M |
| Price / Cash Flow: | 56.26 |
| Annual Sales: | $1.23 |
| Price / Book: | 26.1 |
Profitability
| EPS (TTM): | -0.11000 |
|---|---|
| Net Income (TTM): | $-14.4M |
| Gross Margin: | $219.5M |
| Return on Equity: | -8.4% |
| Return on Assets: | -3.55% |
TG Therapeutics Earnings Forecast
Key TG Therapeutics Financial Ratios
-
The Gross Profit Margin over the past 28 years for TGTX is 93.95%.
-
The Selling, General & Administrative Expenses for TGTX have been equal to 52.51% of Gross Profit Margin.
-
The Research & Development expenses have been 32.61% of Revenue.
-
The Interest Expense is 99.55% of Operating Income.
-
The Net Earning history of TGTX is 5.42% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 14 years.
TG Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TGTX |
| CUSIP: | 88322Q |
| Website: | tgtherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 1.27 |
|---|---|
| Current Ratio: | 4.59 |
| Quick Ratio: | 3.65 |
Price-to-Earnings
| Trailing P/E Ratio: | 358 |
|---|---|
| Forward P/E Ratio: | 34.94 |
TGTX Technical Analysis vs Fundamental Analysis
Buy
60
TG Therapeutics (TGTX)
is a Buy
Is TG Therapeutics a Buy or a Sell?
-
TG Therapeutics stock is rated a BuyThe current TG Therapeutics [TGTX] share price is $32.22. The Score for TGTX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.